Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study.

Thumbnail Image

Embargo End Date

Authors

Zhang, X
Theodoratou, E
Li, X
Farrington, SM
Law, PJ
Broderick, P
Walker, M
Klimentidis, YC
Rees, JMB
Houlston, RS
Tomlinson, IPM
Burgess, S
Campbell, H
Dunlop, MG
Timofeeva, M

Document Type

Journal Article

Date

2021-03-30

Date Accepted

2020-12-08

Abstract

BACKGROUND: We conducted a Mendelian randomisation (MR) study to investigate whether physical activity (PA) causes a reduction of colorectal cancer risk and to understand the contributions of effects mediated through changes in body fat. METHODS: Common genetic variants associated with self-reported moderate-to-vigorous PA (MVPA), acceleration vector magnitude PA (AMPA) and sedentary time were used as instrumental variables. To control for confounding effects of obesity, we included instrumental variables for body mass index (BMI), body fat percentage, waist circumference and arm, trunk and leg fat ratios. We analysed the effect of these instrumental variables in a colorectal cancer genome-wide association study comprising 31,197 cases and 61,770 controls of European ancestry by applying two-sample and multivariable MR study designs. RESULTS: We found decreased colorectal cancer risk for genetically represented measures of MVPA and AMPA that were additional to effects mediated through genetic measures of obesity. Odds ratio and 95% confidence interval (CI) per standard deviation increase in MVPA and AMPA was 0.56 (0.31, 1.01) and 0.60 (0.41, 0.88), respectively. No association has been found between sedentary time and colorectal cancer risk. The proportion of effect mediated through BMI was 2% (95% CI: 0, 14) and 32% (95% CI: 12, 46) for MVPA and AMPA, respectively. CONCLUSION: These findings provide strong evidence to reinforce public health measures on preventing colorectal cancer that promote PA at a population level regardless of body fatness.

Citation

British Journal of Cancer, 2021, 124 (7), pp. 1330 - 1338

Source Title

British Journal of Cancer

Publisher

SPRINGERNATURE

ISSN

0007-0920

eISSN

1532-1827
1532-1827

Research Team

Cancer Genomics

Notes